Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jul;68(1):166–171. doi: 10.1038/bjc.1993.307

Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

B S Bolger 1, T G Cooke 1, R P Symonds 1, A B MacLean 1, P D Stanton 1
PMCID: PMC1968308  PMID: 8318408

Abstract

The pre-treatment cell kinetics of 120 cervical tumours were assessed following the in vivo labelling with the thymidine analogue Bromodeoxyuridine (BrdUrd). In 89% both static and temporal kinetic parameters could be measured. Through the analysis of multiple biopsies from each tumour marked intra tumour heterogeneity was demonstrated. The median values for the most highly labelled sample analysed for each tumour were; S-phase duration (Ts) 12.1 h, BrdUrd labelling index (CLI) 9.5% and potential tumour doubling time 4.4 days. There was a significant elevation in CLI, but no difference in Ts, between tumour and non-neoplastic cervical tissue. There was a significant elevation in CLI, advanced stage and large size tumours. Although a significant elevation in CLI was found in aneuploid tumours this is likely to represent the systemic bias of the calculation methods, with no difference being seen between aneuploid and diploid tumours when BrdUrd labelling was measured with-out reference to the nuclei DNA content. The majority of these patients were treated with radiotherapy and cell kinetic data will be correlated with treatment response when adequate follow up has been achieved.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  2. Bennington J. L. Cellular kinetics of invasive squamous carcinoma of the human cervix. Cancer Res. 1969 May;29(5):1082–1088. [PubMed] [Google Scholar]
  3. Cole D. J., Brown D. C., Crossley E., Alcock C. J., Gatter K. C. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer. 1992 May;65(5):783–785. doi: 10.1038/bjc.1992.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davis J. R., Aristizabal S., Way D. L., Weiner S. A., Hicks M. J., Hagaman R. M. DNA ploidy, grade, and stage in prognosis of uterine cervical cancer. Gynecol Oncol. 1989 Jan;32(1):4–7. doi: 10.1016/0090-8258(89)90840-8. [DOI] [PubMed] [Google Scholar]
  5. Dixon B., Ward A. J., Joslin C. A. Pre-treatment 3H-TdR labelling of cervical biopsies: histology, staging and tumour response to radiotherapy. Clin Radiol. 1977 Sep;28(5):491–497. doi: 10.1016/s0009-9260(77)80060-3. [DOI] [PubMed] [Google Scholar]
  6. Dressler L. G., Seamer L. C., Owens M. A., Clark G. M., McGuire W. L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer. 1988 Feb 1;61(3):420–427. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  7. Hendy-Ibbs P., Cox H., Evan G. I., Watson J. V. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Br J Cancer. 1987 Mar;55(3):275–282. doi: 10.1038/bjc.1987.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kenter G. G., Cornelisse C. J., Aartsen E. J., Mooy W., Hermans J., Heintz A. P., Fleuren G. J. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix. Gynecol Oncol. 1990 Nov;39(2):181–185. doi: 10.1016/0090-8258(90)90429-o. [DOI] [PubMed] [Google Scholar]
  9. Naus G. J., Zimmerman R. L. Prognostic value of flow cytophotometric DNA content analysis in single treatment stage IB-IIA squamous cell carcinoma of the cervix. Gynecol Oncol. 1991 Nov;43(2):149–153. doi: 10.1016/0090-8258(91)90062-a. [DOI] [PubMed] [Google Scholar]
  10. Peel K. R., Khoury G. G., Joslin C. A., O'Donovan P. J., Mgaya H., Keates G., Head C., Thorogood D. J. Cancer of the cervix in women under 40 years of age, a regional survey, 1975-1984. Br J Obstet Gynaecol. 1991 Oct;98(10):993–1000. doi: 10.1111/j.1471-0528.1991.tb15337.x. [DOI] [PubMed] [Google Scholar]
  11. Strang P., Eklund G., Stendahl U., Frankendal B. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Res. 1987 Jul-Aug;7(4B):807–810. [PubMed] [Google Scholar]
  12. Tribukait B. Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother. 1984;1(4):211–218. doi: 10.1007/BF02934525. [DOI] [PubMed] [Google Scholar]
  13. Tubiana M., Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol. 1989 May;15(1):1–18. doi: 10.1016/0167-8140(89)90113-8. [DOI] [PubMed] [Google Scholar]
  14. Wilson G. D. Assessment of human tumour proliferation using bromodeoxyuridine--current status. Acta Oncol. 1991;30(8):903–910. doi: 10.3109/02841869109088242. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES